Overview
Hiroo Hasegawa practices in Nagasaki, Japan. Hasegawa is highly rated in 3 conditions, according to our data. Their top areas of expertise are Adult T-Cell Leukemia, Leukemia, Pneumonia, Methicillin-Resistant Staphylococcus Aureus (MRSA), and Bone Marrow Transplant.
Their clinical research consists of co-authoring 119 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult T-Cell LeukemiaHasegawa isDistinguished. Learn about Adult T-Cell Leukemia.
- Advanced
- LeukemiaHasegawa isAdvanced. Learn about Leukemia.
- PneumoniaHasegawa isAdvanced. Learn about Pneumonia.
- Experienced
- Bone Marrow TransplantHasegawa isExperienced. Learn about Bone Marrow Transplant.
- Chronic Myelogenous Leukemia (CML)Hasegawa isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- COVID-19Hasegawa isExperienced. Learn about COVID-19.
- FluHasegawa isExperienced. Learn about Flu.
- HTLV-1 Associated MyelopathyHasegawa isExperienced. Learn about HTLV-1 Associated Myelopathy.
- Legionnaire DiseaseHasegawa isExperienced. Learn about Legionnaire Disease.